1. Home
  2. CADL vs ORN Comparison

CADL vs ORN Comparison

Compare CADL & ORN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$8.83

Market Cap

578.8M

Sector

Health Care

ML Signal

HOLD

Logo Orion Group Holdings Inc.

ORN

Orion Group Holdings Inc.

HOLD

Current Price

$13.93

Market Cap

555.4M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CADL
ORN
Founded
1999
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
578.8M
555.4M
IPO Year
2021
2007

Fundamental Metrics

Financial Performance
Metric
CADL
ORN
Price
$8.83
$13.93
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
7
4
Target Price
$19.00
$16.25
AVG Volume (30 Days)
2.2M
396.0K
Earning Date
05-14-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
58.62
220.00
EPS
N/A
0.12
Revenue
$125,000.00
$852,260,000.00
Revenue This Year
N/A
$8.50
Revenue Next Year
N/A
$7.83
P/E Ratio
N/A
$117.50
Revenue Growth
N/A
7.01
52 Week Low
$4.35
$6.44
52 Week High
$9.27
$15.85

Technical Indicators

Market Signals
Indicator
CADL
ORN
Relative Strength Index (RSI) 68.29 49.31
Support Level $4.80 $13.20
Resistance Level $9.27 $14.20
Average True Range (ATR) 0.60 0.67
MACD -0.04 -0.19
Stochastic Oscillator 75.28 27.37

Price Performance

Historical Comparison
CADL
ORN

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About ORN Orion Group Holdings Inc.

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada, and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. The concrete segment generates maximum revenue and provides construction services for commercial, industrial, multi-family residential, and public projects, including the data center market.

Share on Social Networks: